Skip to main content
. 2016 Nov 1;7(50):82602–82608. doi: 10.18632/oncotarget.13010

Figure 5. Hyperin inhibits LPS-induced NLRP3 activation.

Figure 5

The values presented are the means ± SEM (n = 12 in each group). #p < 0.01 vs. control group, *p < 0.05 and **p < 0.01 vs. LPS group.